[Company news] Vinh Hoan signed strategic partnership agreement with Pharmaq on large-scale vaccination for pangasius
Aug 23, 2018

HO CHI MINH CITY, VIETNAM – Aug. 22, 2018 – PHARMAQ, a business of the leading global animal health company Zoetis, today announced a long-term strategic partnership agreement with Vinh Hoan, the world’s leading producer and exporter of pangasius with headquarters in Vietnam. The agreement was signed during the VIETFISH Exhibition in Ho Chi Minh City by Mrs. Truong Thi Le Khanh, Chairwoman of Vinh Hoan, and Mr. Morten Nordstad, President of PHARMAQ The ceremony was attended by Mr. Vũ Văn Tám, Deputy Minister of the Ministry of Agriculture and Rural Development in Vietnam.’

The collaboration involves large scale vaccination of pangasius with ALPHA JECT Panga 2, a PHARMAQ vaccine which protects against disease caused by the bacteria Edwardsiella Ictaluri and Aeromonas Hydrophila.  PHARMAQ will also provide Vinh Hoan with fish health services, diagnostic testing, and the introduction of new technologies and R&D activities.

“PHARMAQ has been present in Vietnam for more than ten years, and we see this agreement as an important milestone for the introduction of fish vaccines in Asian aquaculture,” said Morten Nordstad, President of PHARMAQ. “Vaccines are important tools for prevention of fish disease, and they help increase the sustainability of fish farming. In order to develop good fish health solutions, we work closely with visionary and professional farming companies like Vinh Hoan. We highly appreciate the close cooperation we have had with Vinh Hoan since we established ourselves in Vietnam, and we look forward to continue and expand our partnership in the years to come.”

The large-scale adoption of vaccines is a major milestone for the Vietnamese pangasius industry. As already proven in salmonid farming, use of efficacious vaccines can reduce or replace the use of antibiotics in treatment of disease, ensure food safety, and improve sustainability and profitability for fish farmers. Treating the fish prophylactically to prevent disease is also advantageous from an animal welfare perspective. “Our goal is to offer healthy and safe food without environmental and economic trade-offs, and the use of vaccines is essential to reach this objective,” said Ms Vi Tam, CEO of Vinh Hoan.

Siging pic (082218)

Mrs. Khanh Truong – Chairwoman of Vinh Hoan Corporation and Mr. Morten Nordstad, President of PHARMAQ – Part of Zoetis signed the strategic partnership agreement (PC: Vinh Hoan Corporation)

For further information, please contact:

Morten Nordstad,
President PHARMAQ a business of Zoetis
Mobile: +47 907 52 853

About PHARMAQ
PHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people. Production facilities, administration and research and development activities are based in Norway with subsidiaries in Chile, United Kingdom, China, Vietnam, Turkey, Spain, Panama and Singapore. PHARMAQ has approximately 250 employees. The company’s products are marketed in Europe, North and South America, and Asia. For further information, visit the company’s website at www.pharmaq.com

scroll